Technology & Health

New Worlds: Technion to commercialize stem cells

Technology and Health

New Worlds: Technion to commercialize stem cells

The Technion-Israel Institute of Technology and and the Alfred Mann Institute at the Technion (AMIT) have established a new company for commercialization of stem cell technologies developed for over a decade at the stem cell research center headed by Professor Joseph Itskovitz-Eldor from the Technion’s Bruce and Ruth Rappaport Faculty of Medicine.

Click here to read more-->
×